Abbott Laboratories (ABT)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Abbott Laboratories (ABT)
137 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on ABT
- Mike Havrilla(13)
- SA Editor Miriam Metzinger(12)
- Mike Huckman(8)
- Centient Biotech Investor(7)
- Stockerblog (6)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(665)
- SA Editor Eli Hoffmann(412)
- Dividends4Life (312)
- Market Folly(288)
- Alan Brochstein(221)
Most commented on authors
- Mike Havrilla(30)
- Mark Perry(21)
- David Van Knapp(20)
- Alan Brochstein(19)
- David Templeton(18)
- Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
- Seven Top Global Healthcare Stocks in Review
- Hedge Fund Tracking: Eminence Capital (Ricky Sandler), Q3 2008
- High Yielding Stocks Going Ex-Dividend in Mid-January
- Investing in Basic Needs: Hedging Your Expenses
- Is There a Legitimate Case for the Healthcare Providers ETF?
- Five Things Worth Remembering About Healthcare in 2009
- S&P's 2009 Dividend Aristocrats: Who Made the Cut?
- 40 Top Rated Emerging Bio-Pharma Stocks
- Stocks That Should Benefit from 0% Funds Rate
- Expecting Isis Stock to Rise on Abbott Purchase
- Trading on FDA Decisions: BioDelivery Sciences Could Have a Big '09
- Recession-Proof? The Beauty of Big Pharma Is in the Eye of the Beholder
- More Focused Defensive Index
- Dividend Aristocrats Outperform in November
- Stocks Offering 'Healthy' Returns
- Stocks Will Continue to Erode In This Busted Economy
- 5 Health Care Stocks for Value Investors
- Health Innovator's Index: Does R&D Lead to Higher Stock Prices?
- General Electric Moves On Down the Largest Company List
- Who Will Take GM's Place in the Dow?
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Highly Defensive ETFI: Lower Volatility, Higher Returns
- ETFI Global Healthcare Sector PerfomIdex
- 'Great' Companies That Are, Literally, Good to Go
- S&P 500 Stocks Furthest Above and Below Consensus Price Targets
- Winners and Losers in a Democratic Administration
- Healthcare, Energy Sectors Shouldn't Fear Obama
- FDA Watch: Painkillers on the Fall/Winter Agenda
- Volatile Range Trading - Fast Money Recap (10/16/08)
- Three Reasons for Bear - Fast Money Recap (10/15/08)
- Ten Illinois Stocks
- Earnings Preview: Abbott Labs
- Johnson & Johnson Earnings Makes Dollars and Stents
- Getting Beyond the Fear Itself
- Dividend Aristocrats Survived September
- Pharmaceuticals: Pfizer Is a Buy
- A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.
- Biotech Names With Big Potential
- Being Short New York - Fast Money Recap (9/22/08)
- Abbott, Boston Scientific: Rising Stent Stars
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »